We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chest Computed Tomography (CT) Screening Study With Antibody Testing

This study has been withdrawn prior to enrollment.
(Due to lack of funding)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01203579
First Posted: September 16, 2010
Last Update Posted: June 21, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Mayo Clinic
  Purpose
The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.

Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer

Resource links provided by NLM:


Further study details as provided by Mayo Clinic:

Enrollment: 0
Study Start Date: September 2011
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Detailed Description:
EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Current or Former Smokers with >20 pack year history and or family history of lung cancer. Ages 50-75 years old
Criteria
  • Persons 50-75
  • Asymptomatic for lung cancer
  • Current or former (stopped smoking less than 10 years ago) cigarette smokers
  • History of cigarette smoking of at least 20 pack years
  • History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years).
  • Mentally competent individuals to sign an informed consent.
  • Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.
  • A fully informed signed consent form must have been obtained.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01203579


Locations
United States, Minnesota
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: David Midthun, MD Mayo Clinic
  More Information

Responsible Party: David Midthun, MD, Mayo Clinic
ClinicalTrials.gov Identifier: NCT01203579     History of Changes
Other Study ID Numbers: 10-003048
First Submitted: September 15, 2010
First Posted: September 16, 2010
Last Update Posted: June 21, 2012
Last Verified: June 2012

Keywords provided by Mayo Clinic:
CDT-Lung,CT scan,lung cancer detection

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases